28.57

1.14% -0.33

After Hours: 28.66 0.09 +0.32%

Harmony Biosciences Holdings Inc (HRMY)

Overview News Price History Option Chain Financials Why HRMY Down? Discussions Forecast

Harmony Biosciences Holdings Inc stock is traded at $28.57, with a volume of 712.92K. It is down -1.14% in the last 24 hours and up +3.66% over the past month. Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Previous Close:

$28.90

Open:

$28.69

24h Volume:

712.92K

Relative Volume:

0.88

Market Cap:

$1.64B

Revenue:

$772.53M

Net Income/Loss:

$180.90M

P/E Ratio:

9.209

EPS:

3.1024

Net Cash Flow:

$258.73M

1W Performance:

-5.55%

1M Performance:

+3.66%

6M Performance:

-3.05%

1Y Performance:

-11.08%

1-Day Range:

$28.50

$29.00

1-Week Range:

$28.50

$30.96

52-Week Range:

$25.52

$40.93

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Name

Harmony Biosciences Holdings Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(484) 539-9800

Address

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Employee

268

Twitter

Next Earnings Date

2024-10-29

Latest SEC Filings

HRMY's Discussions on Twitter

Compare HRMY with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HRMY Harmony Biosciences Holdings Inc	28.57	1.66B	772.53M	180.90M	258.73M	3.1024
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-21-25	Initiated	Truist	Buy
Jul-10-25	Resumed	Goldman	Neutral
Jun-02-25	Resumed	Oppenheimer	Outperform
Feb-11-25	Initiated	Deutsche Bank	Buy
Dec-17-24	Initiated	H.C. Wainwright	Buy
Oct-10-24	Resumed	Raymond James	Outperform
Sep-10-24	Initiated	UBS	Buy
Jun-21-24	Initiated	Citigroup	Buy
Jan-02-24	Downgrade	BofA Securities	Neutral → Underperform
Sep-25-23	Downgrade	Goldman	Neutral → Sell
Sep-07-23	Initiated	Berenberg	Buy
Apr-20-23	Initiated	BofA Securities	Neutral
Oct-14-22	Upgrade	Janney	Neutral → Buy
Oct-14-22	Upgrade	Jefferies	Hold → Buy
Aug-03-22	Downgrade	Jefferies	Buy → Hold
Jul-13-22	Downgrade	Goldman	Buy → Neutral
Jul-07-22	Initiated	Mizuho	Buy
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight
Dec-01-21	Initiated	Oppenheimer	Outperform
Nov-04-21	Initiated	Raymond James	Outperform
Sep-23-21	Initiated	Needham	Buy
Mar-29-21	Upgrade	Goldman	Neutral → Buy
Sep-14-20	Initiated	Goldman	Neutral
Sep-14-20	Initiated	Jefferies	Buy
Sep-14-20	Initiated	Piper Sandler	Overweight

View All

Harmony Biosciences Holdings Inc Stock (HRMY) Latest News

Nov 02, 2025

Sector ETF performance correlation with Harmony Biosciences Holdings Inc.Fed Meeting & Safe Capital Growth Stock Tips - newser.com

Nov 02, 2025

Is Harmony Biosciences Holdings Inc. stock a top momentum playJobs Report & Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025

Forecasting Harmony Biosciences Holdings Inc. price range with options dataJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com

Nov 02, 2025

Using Python tools to backtest Harmony Biosciences Holdings Inc. strategiesMarket Sentiment Review & Long-Term Growth Plans - newser.com

Nov 02, 2025

How interest rate cuts could boost Harmony Biosciences Holdings Inc. stockJuly 2025 Levels & Daily Oversold Bounce Ideas - newser.com

Nov 02, 2025

Will Harmony Biosciences Holdings Inc. stock gain from lower inflationJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com

Nov 02, 2025

Will Harmony Biosciences Holdings Inc. stock benefit from sector rotation2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com

Nov 02, 2025

Developing predictive dashboards with Harmony Biosciences Holdings Inc. dataJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com

Nov 02, 2025

What Wall Street predicts for Harmony Biosciences Holdings Inc. stock priceWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com

Nov 02, 2025

Y Intercept Hong Kong Ltd Invests $1.56 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Nov 02, 2025

Nov 01, 2025

Q3 2025 Earnings Call - MarketScreener

Nov 01, 2025

ETFs Investing in Harmony Biosciences Holdings, Inc. Stocks - TradingView

Nov 01, 2025

What insider trading reveals about Harmony Biosciences Holdings Inc. stockPortfolio Risk Report & Comprehensive Market Scan Insights - newser.com

Nov 01, 2025

Harmony Biosciences Holdings, I (HRMY) stock forecast and price target - Yahoo! Finance UK

Nov 01, 2025

Truist Financial Reiterates a Buy on Harmony Biosciences (HRMY) - MSN

Nov 01, 2025

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo! Finance Canada

Nov 01, 2025